Traduction et republication de : « Prise en charge de la maladie thromboembolique veineuse associée au cancer chez les populations vulnérables »
- 23 May 2024
- journal article
- research article
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 45 (6) , 366-381
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantationAmerican Journal of Hematology, 2021
- Bleeding outcomes in thrombocytopenic acute leukemic patients with venous thromboembolismeJHaem, 2020
- Bleeding incidence and risk factors among cancer patients treated with anticoagulationAmerican Journal of Hematology, 2019
- Proportion of Cancer Cases Attributable to Excess Body Weight by US State, 2011-2015JAMA Oncology, 2019
- Venous thromboembolism in patients with hematologic malignancy and thrombocytopeniaAmerican Journal of Hematology, 2016
- Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixabanThe Journal of Clinical Pharmacology, 2015
- Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active CancerJAMA, 2015
- Overweight, Obesity, and the Risk of Recurrent Venous ThromboembolismArchives of internal medicine (1960), 2008
- Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug managementCancer, 2007
- Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With CancerArchives of internal medicine (1960), 2002